middle.news
How Telix’s Theranostic Pipeline Is Shaping the Future of Cancer Care
6:01pm on Wednesday 11th of June, 2025 AEST
•
Healthcare
Read Story
How Telix’s Theranostic Pipeline Is Shaping the Future of Cancer Care
6:01pm on Wednesday 11th of June, 2025 AEST
Key Points
FDA approvals for PSMA imaging agents Illuccix and Gozellix
Advancement of therapeutic candidates TLX591, TLX250, TLX101 targeting prostate, kidney, and brain cancers
Expansion into new indications and markets with Zircaix and Pixclara
Investment in global manufacturing infrastructure and AI-enabled precision medicine
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TLX
OPEN ARTICLE